US2007054948A1PendingUtilityA1
Purification of olmesartan medoxomil
Est. expirySep 2, 2024(expired)· nominal 20-yr term from priority
C07D 405/14
38
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a process for purifying olmesartan medoxomil. Also provided is pure olmesartan medoxomil.
Claims
exact text as granted — not AI-modified1 . Olmesartan medoxomil containing less than about 0.15% area by HPLC OLM-acid.
2 . The olmesartan medoxomil of claim 1 , containing less than about 0.13% area by HPLC OLM-acid.
3 . The olmesartan medoxomil of claim 2 , containing less than about 0.12% area by HPLC OLM-acid.
4 . A pharmaceutical composition comprising the olmesartan medoxomil of claim 1 and at least one pharmaceutically acceptable excipient.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.